Yan Borné1, Iram Faqir Muhammad1, Laura Lorés-Motta2, Bo Hedblad1, Peter M Nilsson1, Olle Melander1, Eiko K de Jong2, Anna M Blom3, Anneke I den Hollander2,4, Gunnar Engström1. 1. Department of Clinical Sciences, Lund University, Sweden. 2. Department of Ophthalmology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, The Netherlands. 3. Department of Translational Medicine, Lund University, Sweden. 4. Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, The Netherlands.
Abstract
Purpose: This study explored whether complement factor 3 (C3) in plasma is associated with incidence of diabetes in a population-based cohort. We also identified genetic variants related to C3 and explored whether C3 and diabetes share common genetic determinants. Methods: C3 was analyzed in plasma from 4368 nondiabetic subjects, 46 to 68 years old, from the Malmö Diet and Cancer Study. Incidence of diabetes was studied in relationship to C3 levels during 17.7± 4.4 years of follow-up. Genotypes associated with C3 were identified in a genome-wide association study. Diabetes Genetics Replication and Meta-Analysis and the European Genetic Database were used for in silico look-up. Results: In all, 538 (12.3%) subjects developed diabetes during 18 years of follow-up. High C3 was significantly associated with incidence of diabetes after risk factor adjustments (hazard ratio comparing 4th vs 1st quartile, 1.54 (95% confidence interval, 1.13 to 2.09; P = 0.005). C3 was associated with polymorphisms at the complement factor H locus (P < 10-8). However, no relationship with diabetes was observed for this locus. Another eight loci were associated with C3 with P < 10-5. One of them, the glucose kinase regulatory protein (GCKR) locus, has been previously associated with diabetes. The relationship between C3 levels and the GCKR locus was replicated in the European Genetic Database cohort. Conclusions: Plasma concentration of C3 is a risk marker for incidence of diabetes. The results suggest that this association could, in part, be explained by pleiotropic effects related to the GCKR gene.
Purpose: This study explored whether complement factor 3 (C3) in plasma is associated with incidence of diabetes in a population-based cohort. We also identified genetic variants related to C3 and explored whether C3 and diabetes share common genetic determinants. Methods:C3 was analyzed in plasma from 4368 nondiabetic subjects, 46 to 68 years old, from the Malmö Diet and Cancer Study. Incidence of diabetes was studied in relationship to C3 levels during 17.7± 4.4 years of follow-up. Genotypes associated with C3 were identified in a genome-wide association study. Diabetes Genetics Replication and Meta-Analysis and the European Genetic Database were used for in silico look-up. Results: In all, 538 (12.3%) subjects developed diabetes during 18 years of follow-up. High C3 was significantly associated with incidence of diabetes after risk factor adjustments (hazard ratio comparing 4th vs 1st quartile, 1.54 (95% confidence interval, 1.13 to 2.09; P = 0.005). C3 was associated with polymorphisms at the complement factor H locus (P < 10-8). However, no relationship with diabetes was observed for this locus. Another eight loci were associated with C3 with P < 10-5. One of them, the glucose kinase regulatory protein (GCKR) locus, has been previously associated with diabetes. The relationship between C3 levels and the GCKR locus was replicated in the European Genetic Database cohort. Conclusions: Plasma concentration of C3 is a risk marker for incidence of diabetes. The results suggest that this association could, in part, be explained by pleiotropic effects related to the GCKR gene.
Authors: Yuanren Tong; Lu Pei; Kai Luo; Meiduo Zhao; Jing Xu; Ang Li; Runkui Li; Mingan Yang; Qun Xu Journal: Environ Sci Pollut Res Int Date: 2019-10-22 Impact factor: 4.223
Authors: Atlas Khan; Ning Shang; Lynn Petukhova; Jun Zhang; Yufeng Shen; Scott J Hebbring; Halima Moncrieffe; Leah C Kottyan; Bahram Namjou-Khales; Rachel Knevel; Soumya Raychaudhuri; Elizabeth W Karlson; John B Harley; Ian B Stanaway; David Crosslin; Joshua C Denny; Mitchell S V Elkind; Ali G Gharavi; George Hripcsak; Chunhua Weng; Krzysztof Kiryluk Journal: J Am Soc Nephrol Date: 2021-05-03 Impact factor: 14.978
Authors: László József Barkai; Emese Sipter; Dorottya Csuka; Zoltán Prohászka; Katrine Pilely; Peter Garred; Nóra Hosszúfalusi Journal: Front Immunol Date: 2019-03-20 Impact factor: 7.561
Authors: Chuanyan Wu; Yan Borné; Rui Gao; Maykel López Rodriguez; William C Roell; Jonathan M Wilson; Ajit Regmi; Cheng Luan; Dina Mansour Aly; Andreas Peter; Jürgen Machann; Harald Staiger; Andreas Fritsche; Andreas L Birkenfeld; Rongya Tao; Robert Wagner; Mickaël Canouil; Mun-Gwan Hong; Jochen M Schwenk; Emma Ahlqvist; Minna U Kaikkonen; Peter Nilsson; Angela C Shore; Faisel Khan; Andrea Natali; Olle Melander; Marju Orho-Melander; Jan Nilsson; Hans-Ulrich Häring; Erik Renström; Claes B Wollheim; Gunnar Engström; Jianping Weng; Ewan R Pearson; Paul W Franks; Morris F White; Kevin L Duffin; Allan Arthur Vaag; Markku Laakso; Norbert Stefan; Leif Groop; Yang De Marinis Journal: Nat Commun Date: 2021-11-10 Impact factor: 14.919
Authors: J K C Ribeiro; T V Nascimento; A G Agostinho; R M Freitas; L H P Santos; L M Q Machado; J H Leal-Cardoso; M D Moreira-Gomes; V M Ceccatto Journal: Diabetes Metab Syndr Obes Date: 2020-04-01 Impact factor: 3.168